Per Soelberg Sørensen
Professor emeritus, Professor, emeritus
- 2019
- Published
Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis
Petersen, E. R., Søndergaard, H. B., Laursen, J. H., Olsson, A. G., Börnsen, L., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Bang Oturai, A., 2019, In: Multiple Sclerosis Journal. 25, 9, p. 1298-1305 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders
International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders, I. C. O. S. C. I. A. I. I. M. S. A. N. O. S. D., 2019, In: The Lancet Neurology. 18, 2, p. 185-197 13 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
The changing course of multiple sclerosis: rising incidence, change in geographic distribution, disease course, and prognosis
Magyari, M. & Sørensen, Per Soelberg, 2019, In: Current Opinion in Neurology. 32, 3, p. 320-326Research output: Contribution to journal › Review › Research › peer-review
- 2018
- Published
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., Fujihara, K., Galetta, S. L., Hartung, H. P., Kappos, L., Lublin, F. D., Marrie, R. A., Miller, A. E., Miller, D. H., Montalban, X., Mowry, E. M. & 10 others, , 2018, In: Lancet Neurology. 17, 2, p. 162-173Research output: Contribution to journal › Review › Research › peer-review
- Published
Disability in progressive MS is associated with T2 lesion changes
Ammitzbøll, C., Dyrby, T. B., Lyksborg, M., Schreiber, K., Ratzer, R., Romme Christensen, J., Iversen, P., Magyari, M., Garde, E., Sørensen, Per Soelberg, Siebner, Hartwig Roman & Sellebjerg, Finn Thorup, 2018, In: Multiple Sclerosis and Related Disorders. 20, p. 73-77Research output: Contribution to journal › Journal article › Research › peer-review
- Published
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
Montalban, X., Gold, R., Thompson, A. J., Otero-Romero, S., Amato, M. P., Chandraratna, D., Clanet, M., Comi, G., Derfuss, T., Fazekas, F., Hartung, H. P., Havrdova, E., Hemmer, B., Kappos, L., Liblau, R., Lubetzki, C., Marcus, E., Miller, D. H., Olsson, T., Pilling, S. & 7 others, , 2018, In: Multiple Sclerosis Journal. 24, 2, p. 96-120Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Early versus later treatment start in multiple sclerosis: a register-based cohort study
the Danish Multiple Sclerosis Group, T. D. M. S. G., 2018, In: European Journal of Neurology. 25, 10, p. 1262-e110Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop
Amato, M. P., Derfuss, T., Hemmer, B., Liblau, R., Montalban, X., Sørensen, Per Soelberg, Miller, D. H. & 2016 ECTRIMS Focused Workshop Group, 2. E. F. W. G., 2018, In: Multiple Sclerosis Journal. 24, 5, p. 590-603Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing-remitting multiple sclerosis: the CLARITY Extension study
Comi, G., Cook, S., Rammohan, K., Sørensen, Per Soelberg, Vermersch, P., Adeniji, A. K., Dangond, F. & Giovannoni, G., 2018, In: Therapeutic Advances in Neurological Disorders. 11, p. 1-11Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
Giovannoni, G., Sørensen, Per Soelberg, Cook, S., Rammohan, K., Rieckmann, P., Comi, G., Dangond, F., Adeniji, A. K. & Vermersch, P., 2018, In: Multiple Sclerosis Journal. 24, 12, p. 1594-1604Research output: Contribution to journal › Journal article › Research › peer-review
ID: 11025
Most downloads
-
240
downloads
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
184
downloads
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
159
downloads
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies
Research output: Contribution to journal › Journal article › Research › peer-review
Published